{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:18:27Z","timestamp":1792919907691,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.clml.2017.05.016","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T20:16:35Z","timestamp":1496780195000},"page":"498-505.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic Factors and Outcomes of Adult Lymphoblastic Lymphoma in the United States"],"prefix":"10.1016","volume":"17","author":[{"given":"Mohamed Abd","family":"El-Fattah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2017.05.016_bib1","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","article-title":"Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.016_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2010.08541.x","article-title":"Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951","volume":"152","author":"Ducassou","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2017.05.016_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2011-04-347872","article-title":"Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007","volume":"119","author":"Dores","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.016_bib4","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/annonc\/mdw025","article-title":"Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Hoelzer","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2017.05.016_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.critrevonc.2010.12.003","article-title":"Lymphoblastic lymphoma","volume":"79","author":"Cortelazzo","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clml.2017.05.016_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/1096-911X(200007)35:1<20::AID-MPO4>3.0.CO;2-L","article-title":"Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90","volume":"35","author":"Neth","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.clml.2017.05.016_bib7","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/00000478-200011000-00003","article-title":"Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement","volume":"24","author":"Lin","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2017.05.016_bib8","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia","volume":"99","author":"Hoelzer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.016_bib9","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/cncr.10552","article-title":"The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma","volume":"94","author":"Dabaja","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.05.016_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/annonc\/mdl426","article-title":"Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes","volume":"18","author":"Song","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2017.05.016_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/PAS.0b013e318213e90e","article-title":"Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European Childhood Lymphoma Pathology Panel","volume":"35","author":"Oschlies","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2017.05.016_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1309\/Q5GV-3K00-WAC6-BBUB","article-title":"Precursor B-cell lymphoblastic lymphoma: a study of nine cases lacking blood and bone marrow involvement and review of the literature","volume":"115","author":"Maitra","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2017.05.016_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.12042","article-title":"The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report","volume":"159","author":"Patel","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2017.05.016_bib14","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3324\/haematol.10882","article-title":"Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial","volume":"92","author":"Hunault","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2017.05.016_bib15","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2648::AID-CNCR22>3.0.CO;2-R","article-title":"B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology","volume":"85","author":"Soslow","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.05.016_bib16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2015.61.5385","article-title":"Pediatric-like acute lymphoblastic leukemia therapy in adults with lymphoblastic lymphoma: the GRAALL-LYSA LL03 study","volume":"34","author":"Lepretre","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.05.016_bib17","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.016_bib18","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","volume":"19","author":"Sweetenham","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.05.016_bib19","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/sj.leu.2403095","article-title":"Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87\/93 trials","volume":"17","author":"Le Gouill","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2017.05.016_bib20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.leu.2404156","article-title":"High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2017.05.016_bib21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10428190902926999","article-title":"Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea","volume":"50","author":"Chang","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.05.016_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00277-011-1252-x","article-title":"Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma","volume":"91","author":"Cortelazzo","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2017.05.016_bib23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3109\/0284186X.2014.889850","article-title":"Treatment outcome in T-cell lymphoblastic lymphoma in adults\u2014a population-based study from the Swedish Lymphoma Registry","volume":"53","author":"Ellin","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clml.2017.05.016_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2017.05.016_bib25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","article-title":"Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients","volume":"10","author":"Morel","year":"1992","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.05.016_bib26","first-page":"2269","article-title":"Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas","volume":"17","author":"Yeh","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clml.2017.05.016_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymphoblastic leukemia","volume":"42","author":"Van Vlierberghe","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.clml.2017.05.016_bib28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/leu.2009.277","article-title":"ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence","volume":"24","author":"Yang","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2017.05.016_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12185-014-1585-z","article-title":"Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols","volume":"99","author":"Kobayashi","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2017.05.016_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/10428194.2016.1193860","article-title":"Stem cell transplantation outcomes in lymphoblastic lymphoma","volume":"58","author":"Brammer","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.05.016_bib31","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.2008.19.3367","article-title":"Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the Berlin-Frankfurt-Muenster group","volume":"27","author":"Burkhardt","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.05.016_bib32","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/cncr.11615","article-title":"Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center","volume":"98","author":"Mora","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.05.016_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00277-014-2258-y","article-title":"Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction\u00a0followed by hematopoietic stem cell transplantation","volume":"94","author":"Jeong","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2017.05.016_bib34","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","article-title":"Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993","volume":"106","author":"Rowe","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.016_bib35","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical impact of NOTCH1 and\/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.05.016_bib36","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3109\/10428194.2013.828350","article-title":"Long-term outcomes of modified Berlin-Frankfurt-M\u00fcnster-90 regimen in adults with T-lymphoblastic lymphoma: a single-center experience","volume":"55","author":"Wang","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2017.05.016_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/pbc.25824","article-title":"Prognostic impact of intensified maintenance therapy on children with advanced lymphoblastic lymphoma: a report from the Japanese Pediatric Leukemia\/Lymphoma Study Group: ALB-NHL03 study","volume":"63","author":"Sunami","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2017.05.016_bib38","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL): an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.016_bib39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2014-09-551937","article-title":"How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia","volume":"126","author":"Frey","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.016_bib40","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","article-title":"Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801","volume":"109","author":"DeAngelo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.016_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.2005.02.2707","article-title":"Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma","volume":"24","author":"Burkhardt","year":"2006","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017306365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017306365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:29:41Z","timestamp":1761870581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265017306365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2152265017306365"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2017.05.016","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Factors and Outcomes of Adult Lymphoblastic Lymphoma in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2017.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}